Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 6, 2009, Pages 781-788

  Ramirez, Rafael ^a   Carracedo, Julia ^a   Nogueras, Sonia ^a   Buendia, Paula ^a   Merino, Ana ^a   Cañadillas, Sagrario ^a   Rodríguez, Mariano ^a   Tetta, Ciro ^b   Martin Malo, Alejandro ^a   Aljama, Pedro ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Angiogenesis; Apoptosis; Carbamylated darbepoetin; Cell senescence; Endothelial progenitor cells; Inflammation; Proliferation

Indexed keywords

JANUS KINASE 2; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN;

ANGIOGENESIS; ARTICLE; CARBAMOYLATION; CELL AGING; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

APOPTOSIS; BLOTTING, WESTERN; CELL AGING; CELL LINE; CELL PROLIFERATION; ENDOTHELIAL CELLS; ERYTHROPOIETIN; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; SIGNAL TRANSDUCTION; STEM CELLS; TELOMERE;

EID: 70350586738     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.09.005     Document Type: Article

References (29)

1. Winearls C.G., Oliver D.O., Pippard M.J., Reid C., Downing M.R., and Cotes P.M. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 22 (1986) 1175-1178
2. Ghezzi P., and Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 11 (2004) S37-S44
3. Brines M., and Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 264 (2008) 405-432
4. Bao H., Jacobs-Helber S.M., Lawson A.E., Penta K., Wickrema A., and Sawyer S.T. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93 (1999) 3757-3773
5. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 4 (1999) 434-438
6. Geft D., Schwartzenberg S., and George J. Circulating endothelial progenitor cells in cardiovascular disorders. Expert Rev. Cardiovasc. Ther. 8 (2008) 1115-1121
7. Verma S., Kuliszewski M.A., Li S.H., Szmitko P.E., Zucco L., Wang C.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109 (2004) 2058-2067
8. Ramirez R., Carracedo J., Merino A., Nogueras S., Alvarez-Lara M.A., Rodríguez M., et al. Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int. 72 (2007) 108-113
9. Tousoulis D., Andreou I., Antoniades C., Tentolouris C., and Stefanadis C. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 201 (2008) 236-247
10. Heeschen C., Aicher A., Lehmann R., Fichtlscherer S., Vasa M., Urbich C., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
11. Bahlmann F.H., DeGroot K., Duckert T., Niemczyk E., Bahlmann E., Boehm S.M., et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int. 64 (2003) 1648-1652
12. de Groot K., Bahlmann F.H., Sowa J., Koenig J., Menne J., Haller H., et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int. 66 (2004) 641-646
13. Ramirez R., Martin-Malo A., and Aljama P. Inflammation and hemodiafiltration. Contrib. Nephrol. 158 (2007) 210-215
14. Drüeke T.B., Locatelli F., Clyne N., Eckardt K.U., Macdougall I.C., Tsakiris D., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N. Engl. J. Med. 355 (2006) 2071-2084
15. Leist M., Ghezzi P., Grasso G., Bianchi R., Villa P., Fratelli M., et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
16. Brines M., Grasso G., Fiordaliso F., Sfacteria A., Ghezzi P., Fratelli M., et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14907-14912
17. Komatsu N., Yamamoto M., Fujita H., Miwa A., Hatake K., Endo T., et al. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 82 (1993) 456-464
18. Ratajczak J., Majka M., Kijowski J., Baj M., Pan Z.K., Marquez L.A., et al. Biological significance of MAPK, AKT and JAK-STAT protein activation by various erythropoietic factors in normal human early erythroid cells. Br. J. Haematol. 115 (2001) 195-204
19. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499-2507
20. Hill H.M., Zalos G., Halcox J.P.J., Schenke W.H., Wacliwiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N. Engl. J. Med. 348 (2003) 593-600
21. Teoh M.L., Turner P.V., and Evans D.H. Tumorigenic poxviruses up-regulate intracellular superoxide to inhibit apoptosis and promote cell proliferation. J. Virol. 79 (2005) 799-811
22. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9363-9367
23. Ramirez R., Carracedo J., Jimenez R., Canela A., Herrera E., and Aljama P. Massive telomere loss is an early event of DNA damage-induced apoptosis. J. Biol. Chem. 278 (2003) 836-842
24. Farrell F., and Lee A. The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 9 Suppl 5 (2004) 18-30
25. Asahara T. Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration. Handb. Exp. Pharmacol. 180 (2007) 181-194
26. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10 (2004) 858-864
27. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18 (1999) 3964-3972
28. Jujo K., Ii M., and Losordo D.W. Endothelial progenitor cells in neovascularization of infarcted myocardium. J. Mol. Cell. Cardiol. 45 (2008) 530-544
29. López-Gómez J.M., Portolés J.M., and Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis. and their relation to mortality. Kidney Int. 111 Suppl (2008) 75-81